文献速递衰弱、肌少症与跌倒老年综合评估

基于实验室检验数据的衰弱指数作为研究衰弱对健康结局影响的工具:系统综述与荟萃分析

The frailty index based on laboratory test data as a tool to investigate the impact of frailty on health outcomes: a systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2023-01-01

该系统综述与荟萃分析纳入38项研究,评估基于实验室检验数据的衰弱指数(FI-Lab)预测死亡的能力。FI-Lab每增加0.01单位,总体死亡风险比(HR)为1.04(95%CI 1.03-1.05),平均年龄81岁以上研究HR亦为1.04(95%CI 1.03-1.05),证据质量分别为中等和高。FI-Lab评分较高与更多不良健康结局相关,性别差异不一致。

要点

  • FI-Lab每增加0.01单位,总体死亡风险HR=1.04(95%CI 1.03-1.05)。
  • 平均年龄81岁以上研究中,FI-Lab每增加0.01单位死亡HR=1.04(95%CI 1.03-1.05)。
  • FI-Lab评分较高与更多不良健康结局相关,性别差异无一致结论。

核心结论

  • FI-Lab与死亡风险及多种不良健康结局相关,结论主要适用于65岁以上老年人。
  • FI-Lab评分性别差异不一致,多项研究结论存在分歧。

研究设计与样本

  • 系统综述与荟萃分析,检索6个在线数据库,覆盖2010年1月至2022年7月11日,共纳入38项研究。
  • 从1201篇文献中筛选出测量人类FI-Lab的研究,合并死亡风险比(HR)。

主要发现

  • FI-Lab每增加0.01单位预测总体死亡HR=1.04(95%CI 1.03-1.05),证据质量中等。
  • 平均年龄81岁以上研究中,FI-Lab每增加0.01单位预测死亡HR=1.04(95%CI 1.03-1.05),证据质量高。
  • FI-Lab评分较高与更频繁的不良健康结局相关。
  • FI-Lab评分的性别差异不一致,无一致性别效应迹象。

关键数值与推荐

  • FI-Lab每增加0.01单位,总体死亡风险HR=1.04(95%CI 1.03-1.05)。
  • 平均年龄81岁以上研究,FI-Lab每增加0.01单位死亡HR=1.04(95%CI 1.03-1.05)。

临床怎么用

  • 可将FI-Lab作为老年(65岁以上)患者衰弱评估与死亡风险分层的参考工具。
  • FI-Lab评分较高提示不良健康结局风险增加,可辅助临床决策。

局限性

  • 结论主要适用于65岁以上老年人,年轻人证据不足,需临床与人群代表性研究进一步验证。
  • FI-Lab评分的性别差异研究结论不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The frailty index (FI) quantifies frailty as deficit accumulation. It has been adapted to employ laboratory test data (FI-Lab). Our objective was to systematically review and meta-analyse the FI-Lab's ability to predict mortality. Secondary objectives were to review the FI-Lab's association with adverse health outcomes and whether FI-Lab scores differed between the sexes. A systematic literature search was carried out using six online databases to identify studies that measured the FI-Lab in humans. Hazard ratios (HRs) were combined in a meta-analysis to create a pooled risk estimate for mortality. Of the 1,201 papers identified, spanning January 2010 until 11 July 2022, 38 were included. FI-Lab scores per 0.01 unit increase predicted mortality overall (HR = 1.04; 95% confidence interval (CI) = 1.03-1.05) and for studies with a mean age of 81+ years (HR = 1.04; 95% CI = 1.03-1.05). The quality of evidence for these meta-analyses are moderate and high, respectively. Further, higher FI-Lab scores were associated with more frequent adverse health outcomes. Sex differences in FI-Lab scores varied, with no consistent indication of a sex effect. The FI-Lab is associated with mortality and with a variety of adverse health outcomes. No consistent sex differences in FI-Lab scores were observed, with several studies in disagreement. Notably, these conclusions were most relevant to older (65+ years old) individuals; further evidence in younger people is needed in both clinical and population representative studies.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Sapp DG, Cormier BM, Rockwood K, et al. The frailty index based on laboratory test data as a tool to investigate the impact of frailty on health outcomes: a systematic review and meta-analysis. Age Ageing. 2023. PMID: 36626319. doi:10.1093/ageing/afac309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。